EPRX

Conviction 12HealthcareScan · Thu, Jun 25, 2026

Bullish engulfing

EPRX$6.43+2.88%

ResistanceSupportVol 14

Vol MA14 371.79K

Mar 26Apr 14May 1May 19Jun 8Jun 25

EUPRAXIA PHARMACEUTICALS INC.Biotechnologywww.eupraxiapharma.com ↗

Price6.43

Change+2.88%

Gap-1.12%

Rel volume0.87×

Avg volume335.68K

Avg $ vol2.12M

SMA 206.37

SMA 506.88

SMA 2006.92

Price vs 50-6.56%

Price vs 200-7.05%

MA stackbearish

50/200 crossdeath · 1d

Supertrenddown · 7.16

RSI (14)48

MACD hist0.06

MACD crossbull · 4d

Stoch %K / %D71 / 64

ADX (14)14

+DI / −DI16 / 23

RSI divergence—

MACD divergence—

ATR %+6.86%

ADR %6.37%

52w high9.07

52w low4.31

From 52w high-29.11%

Above 52w low+49.19%

New 52w highNo

SqueezeOff

Bollinger width24.44%

%B0.54

Donchian pos44.32%

Donchian high7.44

Donchian low5.63

AVWAP (52w high)7.35

vs AVWAP high-12.47%

AVWAP (52w low)7.02

vs AVWAP low-8.46%

OBV trendFlat

Chaikin MF (20)-0.10

Today vs 20d0.87×

Avg vol (14d)371.79K

Avg vol (20d)335.68K

Avg $ vol (20d)2.12M

Market cap229.18M

RS 3m (vs SPY)-21.55%

RS 6m (vs SPY)-12.46%

RS line new highNo

Trend template3/8

Technical rank24.4

1 week+2.23%

1 month-14.61%

3 months-9.18%

6 months-8.14%

1 year+47.82%

YTD-15.06%

P/E—

P/B2.79

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current15.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value148.61M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out65.02M

Employees49

ListedWed, Jun 9, 2021

Free float49.6M

Float %83.3%

Short interest4.08M

Days to cover12.3d

Short volume5.2%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs −$0.22

Last surprise-4.5% miss

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank24.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Congress activity

Disclosed STOCK Act trades in EPRX

All disclosures →

No recent disclosed trades by Congress in EPRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EPRX

No recent insider (Form 4) filings in EPRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EPRX · 1 recent

EDGAR →

8-K6-KMon, Jun 22, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.